A hospital in Ningbo, China, is using an artificial-intelligence tool called PANDA to screen routine noncontrast CT scans for pancreatic cancer, leading to early detection and treatment in several patients. The system, developed by researchers affiliated with Alibaba’s Damo Academy, was rolled into a clinical trial at the Affiliated